Skip to content

Study · Measured the body's own peptide · 2017

1 result

Neuropeptide imaging in rat spinal cord with MALDI-TOF MS: Method development for the application in pain-related disease studies.

Sui P, Watanabe H, Artemenko K, Sun W, Bakalkin G, Andersson M, Bergquist J

European journal of mass spectrometry (Chichester, England)7 May 2017Cited by 11 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In naive rat spinal cord, imaging mass spectrometry showed that the distribution of the body's own thymosin beta‑4 matched histological features.

    In plain wordsIn rats, imaging showed that the body's own thymosin beta‑4 in the spinal cord lined up with the tissue structure.

    Outcome
    Not applicableThymosin beta 4 distribution in naive rat spinal cord
    Study

    ratn: not reported in source

    Naive rat spinal cord tissue, MALDI TOF imaging mass spectrometry
    Outcome group
    Pain · Nervous system and cognition

    Source sentences

    Summary
    The imaging result showed that in naive rat spinal cord the molecular distribution of haeme, phosphatidylcholine, substance P and thymosin beta 4 were well in line with histological features.
    1 context sentence
    Summary · context
    This study was the first to investigate pain-related neuropeptide distribution in rat spinal cord using a matrix-assisted laser desorption ionization-time of flight imaging mass spectrometry (MALDI TOF MS) approach.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.